XML 35 R24.htm IDEA: XBRL DOCUMENT v3.25.1
STOCKHOLDERS' DEFICIT (Tables)
 3 Months Ended
Mar. 31, 2025
Equity [Abstract]  
Schedule of Share-Based Payment Arrangement, Cost by Plan
The following table presents the Company's total share based compensation expense by award type:

(In thousands)Three Months Ended
March 31,
20252024
RSUs$5,328 $4,926 
Performance RSUs3,529 2,789 
Options172 765 
Total Share Based Compensation Expense(1)
$9,029 $8,480 
(1) Total share based compensation expense includes $1.6 million and $0.5 million of expense from cash settled awards for the three months ended March 31, 2025 and 2024, respectively.
Schedule of Computation of Income (Loss) per Share
Computation of Loss per Share
(In thousands, except per share data)Three Months Ended
March 31,
 20252024
NUMERATOR:  
Net loss attributable to the Company – common shares$(281,224)$(18,508)
DENOMINATOR(1):
 
Weighted average common shares outstanding - basic152,480 149,795 
  Stock options and restricted stock(2):
— — 
Weighted average common shares outstanding - diluted152,480 149,795 
Net loss attributable to the Company per common share: 
Basic$(1.84)$(0.12)
Diluted(1.84)(0.12)
(1) All of the outstanding Special Warrants are included in both the basic and diluted weighted average common shares outstanding of the Company for the three months ended March 31, 2025 and 2024.
(2) Outstanding equity service awards representing 16.6 million and 15.8 million shares of Class A common stock of the Company for the three months ended March 31, 2025 and 2024, respectively, were not included in the computation of diluted earnings per share because to do so would have been antidilutive.